Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1 - PubMed (original) (raw)
. 2006 Dec 22;281(51):39128-34.
doi: 10.1074/jbc.M610023200. Epub 2006 Oct 30.
Affiliations
- PMID: 17074751
- DOI: 10.1074/jbc.M610023200
Free article
Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1
Hongmei Wang et al. J Biol Chem. 2006.
Free article
Abstract
The mammalian target of rapamycin (mTOR), a critical modulator of cell growth, acts to integrate signals from hormones, nutrients, and growth-promoting stimuli to downstream effector mechanisms involved in the regulation of protein synthesis. Dexamethasone, a synthetic glucocorticoid that represses protein synthesis, acts to inhibit mTOR signaling as assessed by reduced phosphorylation of the downstream targets S6K1 and 4E-BP1. Dexamethasone has also been shown in one study to up-regulate the expression of REDD1 (also referred to RTP801, a novel stress-induced gene linked to repression of mTOR signaling) in lymphoid, but not nonlymphoid, cells. In contrast to the findings of that study, here we demonstrate that REDD1, but not REDD2, mRNA expression is dramatically induced following acute dexamethasone treatment both in rat skeletal muscle in vivo and in L6 myoblasts in culture. In L6 myoblasts, the effect of the drug on mTOR signaling is efficiently blunted in the presence of REDD1 RNA interference oligonucleotides. Moreover, the dexamethasone-induced assembly of the mTOR regulatory complex Tuberin. Hamartin is disrupted in L6 myoblasts following small interfering RNA-mediated repression of REDD1 expression. Finally, overexpression of Rheb, a downstream target of Tuberin function and a positive upstream effector of mTOR, reverses the effect of dexamethasone on phosphorylation of mTOR substrates. Overall, the data support the conclusion that REDD1 functions upstream of Tuberin and Rheb to down-regulate mTOR signaling in response to dexamethasone.
Similar articles
- Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tee AR, et al. Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2. Curr Biol. 2003. PMID: 12906785 - REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch.
Miyazaki M, Esser KA. Miyazaki M, et al. Am J Physiol Cell Physiol. 2009 Mar;296(3):C583-92. doi: 10.1152/ajpcell.00464.2008. Epub 2009 Jan 7. Am J Physiol Cell Physiol. 2009. PMID: 19129461 Free PMC article. - Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis.
Kimball SR, Do AND, Kutzler L, Cavener DR, Jefferson LS. Kimball SR, et al. J Biol Chem. 2008 Feb 8;283(6):3465-3475. doi: 10.1074/jbc.M706643200. Epub 2007 Dec 10. J Biol Chem. 2008. PMID: 18070882 Free PMC article. - Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin.
Kimball SR, Jefferson LS. Kimball SR, et al. Curr Opin Clin Nutr Metab Care. 2004 Jan;7(1):39-44. doi: 10.1097/00075197-200401000-00008. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15090902 Review. - Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis.
Kimball SR, Jefferson LS. Kimball SR, et al. J Nutr. 2006 Jan;136(1 Suppl):227S-31S. doi: 10.1093/jn/136.1.227S. J Nutr. 2006. PMID: 16365087 Review.
Cited by
- REDD1 Is a Promising Therapeutic Target to Combat the Development of Diabetes Complications: A Report on Research Supported by Pathway to Stop Diabetes.
Sunilkumar S, Dennis MD. Sunilkumar S, et al. Diabetes. 2024 Oct 1;73(10):1553-1562. doi: 10.2337/dbi24-0013. Diabetes. 2024. PMID: 38976480 Free PMC article. Review. - Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death.
Yao Y, Yuan M, Shi M, Li W, Sha Y, Zhang Y, Yuan C, Luo J, Li Z, Liao C, Xu K, Niu M. Yao Y, et al. Blood Adv. 2024 Aug 13;8(15):4003-4016. doi: 10.1182/bloodadvances.2023012394. Blood Adv. 2024. PMID: 38820414 Free PMC article. - Regulation of placental amino acid transport in health and disease.
Shimada H, Powell TL, Jansson T. Shimada H, et al. Acta Physiol (Oxf). 2024 Jul;240(7):e14157. doi: 10.1111/apha.14157. Epub 2024 May 6. Acta Physiol (Oxf). 2024. PMID: 38711335 Review. - FGF21 Induces Skeletal Muscle Atrophy and Increases Amino Acids in Female Mice: A Potential Role for Glucocorticoids.
Larson KR, Jayakrishnan D, Soto Sauza KA, Goodson ML, Chaffin AT, Davidyan A, Pathak S, Fang Y, Gonzalez Magaña D, Miller BF, Ryan KK. Larson KR, et al. Endocrinology. 2024 Jan 16;165(3):bqae004. doi: 10.1210/endocr/bqae004. Endocrinology. 2024. PMID: 38244215 - Protective Role of Ethanol Extract of Cibotium barometz (Cibotium Rhizome) against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes.
Kim NH, Lee JY, Kim CY. Kim NH, et al. Int J Mol Sci. 2023 Sep 30;24(19):14798. doi: 10.3390/ijms241914798. Int J Mol Sci. 2023. PMID: 37834245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous